Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
2021;16(9):e0257332
4152-A UNVEILING RACIAL DISCREPANCIES IN THE OUTCOMES OF PORTAL VEIN THROMBOSIS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA - A 5-YEAR NATIONWIDE ANALYSIS Fnu Vikash 1 , Sindhu Vikash 1 , Yassine Kilani 2 , Vikash Kumar 3 , Noor Syed 4 , Sobaan Taj 5 , Abu Abbasi 6 , Syeda Ashna Fatima Kamal 7 , Dushyant Dahiya 8 and Sunny Patel 1 , (1)Jacobi Medical Center/Albert Einstein College of Medicine, (2)Lincoln Medical Center, (3)The Brooklyn Hospital Center, (4)Santa Clara Valley Medical Center, (5)Hackensack Meridian Jersey Shore University Medical Center, (6)Loyola University Medical Center, Chicago, IL, (7)Southern Illinois University (SIU)), (8)The University of Kansas School of Medicine Background: Portal vein thrombosis (PVT) is considered a negative prognostic factor in hepatocellular carcinoma (HCC) patients
Without intrinsic factor, oral B12 cannot be absorbed at all injections are the primary treatment
2025 Jan 1;21(2):725-744
Saudi J Gastroenterol (2013) 19:131
